Sign in

CIK 0001725160

  • Non-accelerated filer
  • Smaller reporting company

Zentalis Pharmaceuticals, Inc.

Sign in to watch
Ticker
ZNTL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
823607803
Phone
+1 858-263-4333
Business address
10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
Former names
Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-04-07 SUN ANTHONY Y President & CEO Purchase +888 $18.00 $16K 2,146,568
2020-04-07 Epperly Melissa B, Chief Financial Officer Grant or award +147,394 277,529
2020-04-07 SUN ANTHONY Y President & CEO Grant or award +303,392 2,145,680
2020-04-07 Johnson David Michael Director Grant or award +51,587 110,648
2020-04-07 Gallagher Cam Director Grant or award +73,478 489,143
2020-04-07 Bunker Kevin D. Chief Operating Officer Grant or award +99,246 544,650
2020-04-07 VIKING GLOBAL INVESTORS LP 10% owner Purchase +725,000 $18.00 $13.1M 4,443,284

Page 32 of 32 · 627 trades